NDC 69339-160-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69339-160
- Requested NDC
- 69339-160-01
- Package NDCs from labels
- 69339-160-01, 69339-160-16, 69339-160-17, 69339-160-18, 69339-160-19
- Manufacturer
- Natco Pharma USA LLC | Strides Pharma, Inc
- Effective date
- 2026-01-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Megestrol Acetate - Natco Pharma USA LLC | Strides Pharma, Inc | Natco Pharma USA LLC | Strides Pharma, Inc | 2026-01-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69339-160-01 | Megestrol Acetate | 10 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 10 | 2 | |
| 69339-160-16 | Megestrol Acetate | 3 in 1 CASE | SUSPENSION | 3 | 2 | |
| 69339-160-16 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-17 | Megestrol Acetate | 4 in 1 CASE | SUSPENSION | 4 | 2 | |
| 69339-160-17 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-18 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-18 | Megestrol Acetate | 5 in 1 CASE | SUSPENSION | 5 | 2 | |
| 69339-160-19 | Megestrol Acetate | 10 in 1 CASE | SUSPENSION | 10 | 2 | |
| 69339-160-19 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69339-160-01 | ML - Milliliter | 69339-160 | 67edb6da-5e2c-4fcc-8a4a-3b098aaff6eb | 1 | 2023-09-05 |
| 69339-160-16 | ML - Milliliter | 69339-160 | 27f6e6c7-08d3-442e-b959-3a663f185453 | 1 | 2023-09-05 |
| 69339-160-17 | ML - Milliliter | 69339-160 | 31b3dcc7-2913-4c24-b3a6-640158ec6c37 | 1 | 2023-09-05 |
| 69339-160-18 | ML - Milliliter | 69339-160 | 59fcc138-63c5-45d5-b946-93f453f55056 | 1 | 2023-09-05 |
| 69339-160-19 | ML - Milliliter | 69339-160 | da7e552a-6eec-4c7f-993b-b3d609d66d99 | 1 | 2023-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener | DOCUSATE SODIUM | Preferred Pharmaceuticals Inc. | 1d9fa4b9-3ec2-4ea2-a05a-ca46cc529167 | 2025-10-01 | Warnings | F05Q2T2JA0 |
| Xpect Industrial Eye Relief | GLYCERIN, NAPHAZOLINE HCL | Cintas Corporation | a0167d06-7adb-36f4-e053-2a95a90af9ef | 2025-09-30 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF CREAM | Neilmed Pharmaceuticals Inc. | 374dc1c0-4243-b272-e063-6394a90a5a6b | 2025-09-24 | Warnings | PDC6A3C0OX |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | Bryant Ranch Prepack | 12f613e4-c919-4cc4-a445-eb30039ae45f | 2025-09-18 | Warnings | F05Q2T2JA0 |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 6b984fa2-4187-45ef-b7d3-15e720abc667 | 2025-09-15 | Warnings | PDC6A3C0OX |
| Megestrol Acetate | MEGESTROL ACETATE | Major Pharmaceuticals | 2c755c6b-32e9-4029-8b70-855007f7375b | 2025-09-15 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Oasis Tears PF Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 640f95f4-c2e8-48ad-ad40-f76bbaddb0dc | 2025-09-12 | Warnings | PDC6A3C0OX |
| Oasis TEARS PF PLUS Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 5d080191-423d-4c0a-b5ae-2ccf5c4a67cb | 2025-09-08 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rising Pharma Holdings, Inc. | db539b39-9504-44d2-9bd5-ba6ffb441024 | 2025-09-08 | Warnings | PDC6A3C0OX |
| Glycerin Children | GLYCERIN | Rising Pharma Holdings, Inc. | 80a5a944-2882-4f8d-a955-ef827cead5f0 | 2025-09-08 | Warnings | PDC6A3C0OX |
| Megestrol Acetate | MEGESTROL ACETATE | Kesin Pharma Corporation | 3bc8708e-a52d-fda2-e063-6294a90a0fbc | 2025-09-02 | Warnings, Adverse reactions | ANDA075671 860225 TJ2M0FR8ES |
| Foaming Facial Cleanser | GLYCERIN, NIACINAMIDE | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c1db9-a5d3-cc82-e063-6294a90a90bb | 2025-08-23 | Warnings | PDC6A3C0OX |
| Refresh RELIEVA PF | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Refresh Optive | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 37e99aa8-02d6-4efb-a862-90bc7fcd5ca5 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Stool Softener | DOCUSATE SODIUM | BJWC (Berkley & Jensen / BJ's) | 330758d2-fc1a-50ce-e063-6294a90a7db1 | 2025-08-19 | Warnings | F05Q2T2JA0 |
| Medique Medi Seltzer | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Unifirst First Aid Corporation | 528da9d9-2a52-4c16-b7b2-61b3eee1abea | 2025-08-19 | Warnings | 2968PHW8QP |
| Upside Down Pain Relief | BENZOCAINE, GLYCERIN | Fridababy, LLC | 31c2cd25-1fec-5ec5-e063-6394a90a24b4 | 2025-08-15 | Warnings | PDC6A3C0OX |
| Sennosides and Docusate Sodium | SENNOSIDES AND DOCUSATE SODIUM | American Health Packaging | 4b84d5d7-43cf-47bb-af59-088550c3a0bc | 2025-08-12 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.